| Literature DB >> 21455249 |
Abstract
Seemingly contrasting genetic backgrounds in anti-citrullinated-protein antibody (ACPA)-positive and ACPA-negative rheumatoid arthritis (RA) support the notion that these are in fact two distinct disease subsets, with different underlying pathogenesis, that might need tailored treatment strategies.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21455249 DOI: 10.1038/nrrheum.2011.28
Source DB: PubMed Journal: Nat Rev Rheumatol ISSN: 1759-4790 Impact factor: 20.543